However, it has been shown in ovarian cancer that the prognostic value of CD44 may depend on its isoform, with the transmembrane form indicating a better prognosis, while the presence of the soluble extracellular domain was associated with a worse prognosis (166). The gene discussed is CD44; the disease is ovarian cancer.